S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ELTX Elicio Therapeutics Inc

5.53

0.39 (7.59%)

Last Updated: 14:33:25

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024
Thursday 12 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
Tuesday 3 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

More Elicio Therapeutics Inc News Articles

RespireRx Pharmaceuticals (CE)

Fannie Mae (QB)

TPT Global Tech (CE)

Bioelectronics (PK)

Anavex Life Sciences

Global Developments (PK)

Rennova Health (CE)

Tonix Pharmaceuticals

Lightwave Logic

Accredited Solutions (PK)

GBT Technologies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions